Advertisement

Topics

Sandoz flexes its biosimilar muscles with Humira and Rituxan data

11:30 EST 14 Nov 2017 | thePharmaLetter

A few companies have taken big strides in moving their biosimilar portfolios forward in Europe and the…

Original Article: Sandoz flexes its biosimilar muscles with Humira and Rituxan data

NEXT ARTICLE

More From BioPortfolio on "Sandoz flexes its biosimilar muscles with Humira and Rituxan data"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...